Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections

Clinical trial NCT02569541 · COMPLETED

Trial details

NCT number: NCT02569541
Sponsor: Arrevus Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Refractory Bone or Joint Infections

Start date: 2015-12-01
Primary completion: 2017-10-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.